HORIZON P3 AD Monotherapy Induction
Research payments
$812,271
Through program year 2024, $812,271 in research payments was reported against HORIZON P3 AD Monotherapy Induction, across 76 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $812,271 | 76 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Barbara Baxter Dallas, TX Named on 2 payments
- Benjamin Ehst Portland, OR Named on 2 payments
- Dowling Stough Hot Springs, AR Named on 2 payments
- Brad Glick Margate, FL Named on 2 payments
- Emma Guttman New York, NY Named on 2 payments
- Manuel Sanchez Hialeah, FL Named on 2 payments
- Stacy Smith Encinitas, CA Named on 2 payments
- Hollis Clark Murray, KY Named on 2 payments
- Christian Mayaud New York, NY Named on 2 payments
- Tina Bhutani San Francisco, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.